site sponsored by
Tag Archive | "president-obama"
Tags: berwick, centers, congress, hard-fight, institute, medicaid, president, president-obama, the-top
Berwick Appointed Head of CMS
Posted on 08 July 2010
Posted in RegulatoryComments (0)
Tags: amend-the-label, because-the-fda, clinical-trials, come-off-patent, data, drug, drug-as-needed, drugs-the-drug, from-the-market, health, medications, president, president-obama, sales, the-drug
As the screws tighten on the drug industry patients will ultimately be the real losers
Posted on 10 May 2010
Posted in DTCComments (0)
Tags: changes-elevate, chief-executive, country, from-the-obama, improvement, institute, make-the-ideal, nation, obama, president, president-obama, the-improvement, united
Obama to Appoint CMS Head Who Has Pursued Perfection
Posted on 29 March 2010
Posted in RegulatoryComments (0)
Tags: analysis, calls-it-quits, democrats, drug, earlier-the-fda, industry, legislation, objections, president-obama, resumed-on-ctic, sales, street-journal, trading-resumed
Biotech wins 12-year haven with passage of reform bill
Posted on 22 March 2010
Posted in Top NewsComments (0)
Tags: country, current affairs, developing, health, legislation, medical, president, president-obama, role, room-as-their, source, the-legislation
Yes They Did! Now What? Opportunities in the Wake of Health Care Reform
Posted on 22 March 2010
Posted in RegulatoryComments (0)
Tags: character, country, determination, fda policy, film, obama, pharmaceutical, president-obama, time
Health Care Reform and Its Impact on FDA and Pharma
Posted on 01 March 2010
Posted in RegulatoryComments (0)
Tags: allowed-the-arm, biotech, condition, fund-regulatory, like-shortening, major-challenge, molecules-make, new-treatments, president-obama, Regulatory, safety, strategic-shift, time
FDA, NIH partnership promises better science, faster reviews
Posted on 25 February 2010
Posted in Top NewsComments (0)
Tags: allowed-the-arm, anthera, biotech ipo, bit-reluctant, companies-eager, condition, enthusiasm, initial-public, larger-pharmas, president-obama, strategic-shift, time, whet-investors
Anthera delays IPO and sends a chilling message
Posted on 25 February 2010
Posted in Top NewsComments (0)
Tags: additional-cuts, antiviral-agent, biotechnology, healthcare reform, house, pass-the-public, president, president-obama, study, technology, zagreb-croatia
BIO chief maps salvage plan for the 12-year umbrella
Posted on 09 February 2010
Posted in Top NewsComments (0)
Tags: director, government, internet, medical, national-survey, president-obama, social, weekly roundup
Weekly Roundup - 12/4/09
Posted on 05 December 2009
Posted in RegulatoryComments (0)
Ask Our Experts
Heather R. Powell
Regulatory
Dawn Obermoeller
Social Media
Jonathan Richman
Non-Personal Promotion
Optimize RX
Internet Marketing & Analytics
Share Your Knowledge
We are always seeking seasoned pharmaceutical marketing professonals as contributors. If you have a strong background in pharmacetical marketing, and are interested in sharing your skills and knowledge with our community, or syndicating your existing blog posts, please click here.
- Popular
- Latest
- Comments
- Tags
- Subscribe
- J&J Prostate Cancer Drug Boosts Survival
- Bristol-Myers starts tender offer for ZymoGenetics
- Yet Another Reason That Sanofi-Genzyme Deal Will Go Through
- Savient: Drug Approval or Another Delay?
- MedImmune Bets Its Fate on âBiobettersâ
- Tekmira to delay start of trial for TKM-ApoB
- Weekly Roundup - 09/10/10
- J&J unit’s prostate cancer drug improves survival
- FDA: Don’t believe everything you read on drug studies
- Top 10 reasons you should join us for the Multi Channel Pharma Marketing Event?
- Optimize RX: yep - recvd - thanks - how much daily u.v.'s r u g...
- JMB: This is another bashing article from an author who...
- Martin: It's just silly of you to obsess over the possibil...
- Gregg Feris: Jon, Thanks for the in depth reply. I like the ...
- Doc: Why should Exxon have to pay this fine for somethi...
2009
adpharm
adpharm gallery
advertising
alpha
biotech
bnet
branded
business
development
drug
DTC
english
europe
fda
fierce-biotech
fierce pharma
gallery
hcp
health
industry
internet
largest
marketing
motley-fool
News
north
north america
north_america
online
online-pharmaceutical
pharma
Print
print_ad
Regulatory
sales
seeking-alpha
single-page
Social Media
technology
the-gallery
the-largest
time
usa
wsj
Stay up to date
- Subscribe to the RSS Feed
